ARTICLE | Company News
Xoma ends Zephyr BPI deal
July 16, 2005 12:28 AM UTC
XOMA said it terminated its 2004 licensing agreement with Zephyr (Carlsbad, Calif.) to develop products related to bactericidal/permeability-increasing (BPI) protein, including XOMA's Neuprex opebecan...